{"count":2,"dbMs":93.6826130002737,"query":{"filter":{"$and":[{"$or":[{"hide_reason":null},{"hide_reason":{"$exists":false}}]},{"type":"Startup","stage":"Public","tags":{"$all":["neuroscience"]}}]},"sort":{},"limit":50,"skip":0,"projection":{"_id":1,"urlname":1,"name":1,"type":1,"stage":1,"raised":1,"primary_sector":1,"founded_year":1,"employees":1,"website":1,"logourl":1,"oneliner":1}},"results":[{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwJ2g-5UKDA","urlname":"neurosense-therapeutics","type":"Startup","name":"NeuroSense Therapeutics","oneliner":"Drug for ALS","website":"https://www.neurosense-tx.com","founded_year":2017,"employees":"11-50","raised":24200000,"stage":"Public","primary_sector":"Health Tech & Life Sciences","logourl":"https://storage.googleapis.com/clean-finder-353810/$aEgwdkktSYPjUzuPglwBHh6xNio1xLTUPBWvyTfSTlVsT23D6dbvay"},{"_id":"ATRACPhfHPV90AEahDh0DcP2gsBkQAKvjRUc7bgYgWWksvxsGE7Glo","urlname":"nurexone-biologic","type":"Startup","name":"NurExone Biologic","oneliner":"EV-based Drug Platform to Treat Damage in the Central Nerve System ","website":"https://nurexone.com/","founded_year":2020,"employees":"11-50","raised":9528000,"stage":"Public","primary_sector":"Health Tech & Life Sciences","logourl":"https://storage.googleapis.com/clean-finder-353810/$G5mXrEm0KANbFKqTOBhffaTMLJbA8BPU7gjdf9lMRcVhAFFNXCAdWG.jpg"}]}